GemPharmatech Co., Ltd. (SHA:688046)

GemPharmatech Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	752.13	686.28	621.73	515.67	392.44	260.45
Other Revenue	0.56	0.56	0.45	0.87	1.34	1.47
Revenue	752.7	686.84	622.19	516.55	393.79	261.92
Revenue Growth (YoY)	11.13%	10.39%	20.45%	31.17%	50.35%	35.91%
Cost of Revenue	283.15	261.33	202.86	150.22	101.27	73.99
Gross Profit	469.55	425.51	419.33	366.33	292.51	187.92
Selling, General & Admin	247.33	239.68	199.61	174.76	134.42	79.43
Research & Development	86.13	87.13	96.6	82.93	55.2	48.22
Other Operating Expenses	24.57	3.57	2.61	1.72	1.59	-36.65
Operating Expenses	364.11	333.68	307.91	267.94	196.11	94.35
Operating Income	105.43	91.83	111.42	98.39	96.4	93.57
Interest Expense	-5.54	-4.3	-2.76	-0.5	-0.74	-0.72
Interest & Investment Income	15.36	22.39	28.65	23.73	14.43	7.91
Currency Exchange Gain (Loss)	1.69	1.69	0.08	1.49	-0.19	-0.76
Other Non Operating Income (Expenses)	-19.69	-21.56	-20.92	-11.32	-16.05	-8.64
EBT Excluding Unusual Items	97.25	90.06	116.48	111.8	93.84	91.35
Gain (Loss) on Sale of Investments	2.18	2.34	2.73	-0.05	0.32	-
Gain (Loss) on Sale of Assets	-0.02	0.01	-0.02	-0.1	0.05	-
Asset Writedown	3.57	-	-	-	-	-
Other Unusual Items	37.19	26.8	42.1	62.03	49.1	-
Pretax Income	140.18	119.22	161.29	173.68	143.31	91.35
Income Tax Expense	18.67	9.4	2.37	9.02	18.39	14.92
Earnings From Continuing Operations	121.51	109.82	158.91	164.67	124.93	76.43
Net Income	121.51	109.82	158.91	164.67	124.93	76.43
Net Income to Common	121.51	109.82	158.91	164.67	124.93	76.43
Net Income Growth	-12.85%	-30.89%	-3.49%	31.81%	63.45%	152.21%
Shares Outstanding (Basic)	405	407	407	392	357	364
Shares Outstanding (Diluted)	405	407	407	392	357	364
Shares Change (YoY)	-1.19%	-0.18%	3.93%	9.84%	-1.93%	-
EPS (Basic)	0.30	0.27	0.39	0.42	0.35	0.21
EPS (Diluted)	0.30	0.27	0.39	0.42	0.35	0.21
EPS Growth	-11.80%	-30.77%	-7.14%	20.00%	66.67%	-
Free Cash Flow	74.85	-23.36	-89.33	-84.33	24.24	-37.28
Free Cash Flow Per Share	0.18	-0.06	-0.22	-0.21	0.07	-0.10
Dividend Per Share	0.110	0.140	0.160	0.041	-	-
Dividend Growth	-42.10%	-12.50%	290.24%	-	-	-
Gross Margin	62.38%	61.95%	67.40%	70.92%	74.28%	71.75%
Operating Margin	14.01%	13.37%	17.91%	19.05%	24.48%	35.73%
Profit Margin	16.14%	15.99%	25.54%	31.88%	31.72%	29.18%
Free Cash Flow Margin	9.94%	-3.40%	-14.36%	-16.33%	6.16%	-14.23%
EBITDA	198.32	164.62	157.42	135.68	125.2	110.41
EBITDA Margin	26.35%	23.97%	25.30%	26.27%	31.80%	42.15%
D&A For EBITDA	92.88	72.79	46	37.29	28.81	16.83
EBIT	105.43	91.83	111.42	98.39	96.4	93.57
EBIT Margin	14.01%	13.37%	17.91%	19.05%	24.48%	35.73%
Effective Tax Rate	13.32%	7.88%	1.47%	5.19%	12.83%	16.33%
Revenue as Reported	752.7	686.84	622.19	516.55	393.79	-
Advertising Expenses	-	2.93	4.69	8.94	2.87	2.01

Source: S&P Global Market Intelligence. Standard template. Financial Sources.